Research ArticleVaccines

MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans

See allHide authors and affiliations

Science Translational Medicine  17 Jun 2020:
Vol. 12, Issue 548, eaaz7715
DOI: 10.1126/scitranslmed.aaz7715

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article